Let's get ready for London

Article

It's that time of year again and I'm sure most of you will be getting ready for Europe's largest annual congress, the 24th Congress of the ESCRS. I have to admit, although I have lived in England my whole life, London never ceases to amaze me. It's busy, expensive and sometimes can feel quite impersonal. That aside, it is a remarkable city. Its cosmopolitan nature gives rise to an eclectic mix of, amongst many other things, restaurants, bars, parks, theatres and shops. It's quite easy to feel spoilt for choice. So while you're visiting our wonderful capital, make sure you get out and sample the delights the city has to offer. Our quick guide to getting out and about in London (ESCRS Congress preview) gives you a little taste of what you might expect.

For those of you who will not be attending this year's congress, I'm pleased to say that you do not need to miss out on the action. Ophthalmology Times Europe can deliver news from the event, throughout the duration of the congress, direct to your desktop, ensuring you don't miss any of the important announcements. If you would like to receive our e-news daily update, just go to our website ( http://www.oteurope.com/) and subscribe for free to our e-newsletter.

I, and the rest of the Ophthalmology Times Europe team, look forward to seeing you in London.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.